Argos Therapeutics' Series D Round

Argos Therapeutics raised a round of funding on April 24, 2012.

Argos Therapeutics, formerly Merix Bioscience, s a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infe…

Articles about Argos Therapeutics' Series D Round: